PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50325F80025Prussian BLUE (radiogardase) insoluble CAP 500mg — Heyltex Corp

Heyltex Corp holds $8.9M across 7 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns

Awarding office

Heyltex Corp

Recipient

Sep 29, 2027

PoP end

$16.2M

Obligated

$16.2M

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number75A50325F80025

Also listed asV797D70258-75A50325F80025

AgencyAspr/Orm-Sns

Awarding officeAspr/Orm-Sns

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentHeyltex Corp

CAGE3QJU3

UEIGY2TKDGQA2L7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVV797D70258

Place of performanceKATY TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 30, 2025

PoP end (current)Sep 29, 2027

Obligated$16.2M

Current value$16.2M

Potential value$16.2M

PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG is a federal award for Aspr/Orm-Sns held by Heyltex Corp. Estimated value $16.2M ($16.2M obligated). Current period of performance ends Sep 29, 2027. Last award drew 1 bidder. Place of performance: KATY TX.

PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG

Recompete timing

Public

● Expiring in 367 days

Current PoP ends Sep 29, 2027 (367 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Bonuses end Sept 30

Want the durability read on 75A50325F80025? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Heyltex Corp — $8.9M obligated across 7 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($8.9M) · all agencies

Department of Health and Human Services (HHS)$7.9M · 89%Department of Veterans Affairs (VA)$1.0M · 11%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50325F80025?

75A50325F80025 (Prussian BLUE (radiogardase) insoluble CAP 500mg) is a Aspr/Orm-Sns award with a potential value of $16.2M, currently held by Heyltex Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50325F80025?

Aspr/Orm-Sns awarded 75A50325F80025 to Heyltex Corp (potential $16.2M).

Who is the incumbent on 75A50325F80025?

Heyltex Corp is the incumbent with $8.9M across 7 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Heyltex Corp’s 75A50325F80025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50325F80025? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Aug 21, 2026